cresemba powder for concentrate for solution for infusion 200mg
pfizer (malaysia) sdn. bhd. - isavucozanium sulfate -
paxlovid
pfizer new zealand limited - nirmatrelvir 150mg; ; ; ; ritonavir 100mg - film coated tablet - active: nirmatrelvir 150mg excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate microcrystalline cellulose opadry pink 05b140011 purified water sodium stearyl fumarate active: ritonavir 100mg - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid- 19) in adults 18 years of age and older, who do not require initiation of supplemental oxygen due to covid-19 and are at increased risk of progression to hospitalisation or death.
cresemba
basilea pharmaceutica deutschland gmbh - isavuconazole - aspergillosis - cresemba is indicated in adults for the treatment of:invasive aspergillosismucormycosis in patients for whom amphotericin b is inappropriateconsideration should be given to official guidance on the appropriate use of antifungal agents.
paxlovid tablet
pfizer canada ulc - ritonavir; nirmatrelvir - tablet - 100mg; 150mg - ritonavir 100mg; nirmatrelvir 150mg
paxlovid tablet
pfizer canada ulc - ritonavir; nirmatrelvir - tablet - 100mg; 150mg - ritonavir 100mg; nirmatrelvir 150mg
kaletra oral solution
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - solution (oral) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
kaletra oral solution
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - solution (oral) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
paxlovid film-coated tablets
pfizer private limited - nirmatrelvir; ritonavir - tablet, film coated - nirmatrelvir 150 mg; ritonavir 100 mg
paxlovid nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack
pfizer australia pty ltd - ritonavir, quantity: 100 mg - tablet, film coated - excipient ingredients: macrogol 3350; macrogol 400; sodium stearylfumarate; titanium dioxide; calcium hydrogen phosphate; sorbitan monolaurate; copovidone; hyprolose; purified talc; polysorbate 80; hypromellose; colloidal anhydrous silica - paxlovid has provisional approval for the treatment of coronavirus disease 2019 (covid-19) in adults 18 years of age and older, who do not require initiation of supplemental oxygen due to covid-19 and are at increased risk of progression to hospitalisation or death (see section 5.1 pharmacodynamic properties, clinical trials).,the decision has been made on the basis of short term efficacy and safety data. continued approval of this indication depends on the efficacy and safety data from ongoing clinical trials and post-market assessment.
cresemba 100 milligram/1 capsule
شركة أدوية الحكمة - hikma pharmaceuticals - isavuconazole 100 milligram/1 capsule - 100 milligram/1 capsule